{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T20:10:06Z","timestamp":1760299806010,"version":"3.44.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["americanjournalofsurgery.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Surgery"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.amjsurg.2018.02.020","type":"journal-article","created":{"date-parts":[[2018,2,17]],"date-time":"2018-02-17T12:24:50Z","timestamp":1518870290000},"page":"326-330","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Differences between palpable and nonpalpable tumors in early-stage, hormone receptor-positive breast cancer"],"prefix":"10.1016","volume":"216","author":[{"given":"Stephanie L.","family":"Warren","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neal","family":"Bhutiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven C.","family":"Agle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"II","given":"Robert C.G.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly M.","family":"McMasters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Ajkay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.amjsurg.2018.02.020_bib1","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1002\/(SICI)1097-0142(19980901)83:5<948::AID-CNCR21>3.0.CO;2-U","article-title":"Prediction of axillary lymph node involvement of women with invasive breast carcinoma: a multivariate analysis","volume":"83","author":"Olivotto","year":"1998","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.amjsurg.2018.02.020_bib2","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1002\/(SICI)1097-0142(19970515)79:10<1918::AID-CNCR12>3.0.CO;2-Y","article-title":"Predictors of axillary lymph node metastases in patients with T1 breast carcinoma","volume":"79","author":"Barth","year":"1997","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.amjsurg.2018.02.020_bib3","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s00268-001-0003-x","article-title":"Predicting axillary nodal positivity in 2282 patients with breast carcinoma","volume":"25","author":"Silverstein","year":"2001","journal-title":"World J Surg"},{"issue":"1","key":"10.1016\/j.amjsurg.2018.02.020_bib4","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/(SICI)1096-9098(199705)65:1<34::AID-JSO7>3.0.CO;2-P","article-title":"Identification of women with T1-T2 breast cancer at low risk of positive axillary nodes","volume":"65","author":"Fein","year":"1997","journal-title":"J\u00a0Surg Oncol"},{"issue":"5","key":"10.1016\/j.amjsurg.2018.02.020_bib5","first-page":"395","article-title":"Nonpalpable versus palpable invasive breast tumors treated with breast-conserving surgical management","volume":"62","author":"Tafra","year":"1996","journal-title":"Am Surg"},{"issue":"9","key":"10.1016\/j.amjsurg.2018.02.020_bib6","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s10434-001-0705-1","article-title":"Palpable breast cancers are inherently different from nonpalpable breast cancers","volume":"8","author":"Skinner","year":"2001","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.amjsurg.2018.02.020_bib7","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1046\/j.1524-4741.2003.09107.x","article-title":"Palpable breast carcinomas: a hypothesis for clinically relevant lymphatic drainage in sentinel lymph node biopsy","volume":"9","author":"Chao","year":"2003","journal-title":"Breast J"},{"issue":"7","key":"10.1016\/j.amjsurg.2018.02.020_bib8","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1093\/annonc\/mdt179","article-title":"Breast cancer phenotype, nodal status and palpability may be useful in the detection of overdiagnosed screening-detected breast cancers","volume":"24","author":"Brouckaert","year":"2013","journal-title":"Ann Oncol"},{"issue":"15","key":"10.1016\/j.amjsurg.2018.02.020_bib9","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1001\/jama.2015.13183","article-title":"Benefits and harms of breast cancer screening: a systematic review","volume":"314","author":"Myers","year":"2015","journal-title":"J\u00a0Am Med Assoc"},{"issue":"9168","key":"10.1016\/j.amjsurg.2018.02.020_bib10","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(98)07413-3","article-title":"14 years of follow-up from the Edinburgh randomised trial of breast-cancer screening","volume":"353","author":"Alexander","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.amjsurg.2018.02.020_bib11","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/jncimono\/1997.22.63","article-title":"Reduced breast cancer mortality in women under age 50: updated results from the malmo mammographic screening program","volume":"22","author":"Andersson","year":"1997","journal-title":"J\u00a0Natl Canc Inst Monogr"},{"issue":"10","key":"10.1016\/j.amjsurg.2018.02.020_bib12","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1002\/cncr.11361","article-title":"The Gothenburg breast screening trial","volume":"97","author":"Bjurstam","year":"2003","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.amjsurg.2018.02.020_bib13","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/bjc.1991.477","article-title":"Breast screening, prognostic factors and survival--results from the Swedish two county study","volume":"64","author":"Duffy","year":"1991","journal-title":"Br J Canc"},{"issue":"3","key":"10.1016\/j.amjsurg.2018.02.020_bib14","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF01806383","article-title":"Analysis of interval breast carcinomas in a randomized screening trial in Stockholm","volume":"9","author":"Frisell","year":"1987","journal-title":"Breast Canc Res Treat"},{"issue":"9","key":"10.1016\/j.amjsurg.2018.02.020_bib15","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/S1470-2045(15)00128-X","article-title":"Effect of mammographic screening from age 40 years on breast cancer mortality in the UK Age trial at 17 years' follow-up: a randomised controlled trial","volume":"16","author":"Moss","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.amjsurg.2018.02.020_bib16","doi-asserted-by":"crossref","unstructured":"Shapiro S. Periodic screening for breast cancer: the HIP randomized controlled trial. Health Insur Plan. J Natl Canc Inst Monogr. 1997(22):27-30.","DOI":"10.1093\/jncimono\/1997.22.27"},{"key":"10.1016\/j.amjsurg.2018.02.020_bib17","doi-asserted-by":"crossref","first-page":"g366","DOI":"10.1136\/bmj.g366","article-title":"Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial","volume":"348","author":"Miller","year":"2014","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.amjsurg.2018.02.020_bib18","doi-asserted-by":"crossref","first-page":"e332","DOI":"10.3747\/co.23.2881","article-title":"Is clinical breast examination important for breast cancer detection?","volume":"23","author":"Provencher","year":"2016","journal-title":"Curr Oncol"},{"issue":"10","key":"10.1016\/j.amjsurg.2018.02.020_bib19","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1002\/cncr.24940","article-title":"Excellent outcomes with adjuvant toremifene or tamoxifen in early stage breast cancer","volume":"116","author":"Lewis","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.amjsurg.2018.02.020_bib20","unstructured":"National Comprehensive Cancer Network G. Breast Cancer Screening and Diagnosis (Version 1.2016). https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/breast-screening.pdf. Accessed March 10, 2017."},{"issue":"15","key":"10.1016\/j.amjsurg.2018.02.020_bib21","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1001\/jama.2015.12783","article-title":"Breast cancer screening for women at average risk: 2015 guideline update from the American cancer Society","volume":"314","author":"Oeffinger","year":"2015","journal-title":"J\u00a0Am Med Assoc"},{"issue":"4","key":"10.1016\/j.amjsurg.2018.02.020_bib22","doi-asserted-by":"crossref","first-page":"279","DOI":"10.7326\/M15-2886","article-title":"Screening for breast cancer: U.S. Preventive services task force recommendation statement","volume":"164","author":"Siu","year":"2016","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjsurg.2018.02.020_bib23","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13058-015-0525-z","article-title":"Benefits and harms of mammography screening","volume":"17","author":"Loberg","year":"2015","journal-title":"Breast Canc Res"},{"issue":"6","key":"10.1016\/j.amjsurg.2018.02.020_bib24","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/bcr1354","article-title":"Overdiagnosis and overtreatment of breast cancer: estimates of overdiagnosis from two trials of mammographic screening for breast cancer","volume":"7","author":"Duffy","year":"2005","journal-title":"Breast Canc Res"},{"issue":"Suppl 1","key":"10.1016\/j.amjsurg.2018.02.020_bib25","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1258\/jms.2012.012082","article-title":"Overdiagnosis in mammographic screening for breast cancer in Europe: a literature review","volume":"19","author":"Puliti","year":"2012","journal-title":"J\u00a0Med Screen"},{"key":"10.1016\/j.amjsurg.2018.02.020_bib26","doi-asserted-by":"crossref","first-page":"b2587","DOI":"10.1136\/bmj.b2587","article-title":"Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends","volume":"339","author":"Jorgensen","year":"2009","journal-title":"BMJ."},{"issue":"6","key":"10.1016\/j.amjsurg.2018.02.020_bib27","first-page":"CD001877","article-title":"Screening for breast cancer with mammography","author":"Gotzsche","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"21","key":"10.1016\/j.amjsurg.2018.02.020_bib28","doi-asserted-by":"crossref","first-page":"5222","DOI":"10.1158\/1078-0432.CCR-10-1282","article-title":"A\u00a0comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor-positive breast cancer","volume":"16","author":"Nielsen","year":"2010","journal-title":"Clin Canc Res Offic J Am Assoc Canc Res"},{"issue":"18","key":"10.1016\/j.amjsurg.2018.02.020_bib29","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1093\/jnci\/djp241","article-title":"The contribution of clinical breast examination to the accuracy of breast screening","volume":"101","author":"Chiarelli","year":"2009","journal-title":"J\u00a0Natl Canc Inst"},{"issue":"9793","key":"10.1016\/j.amjsurg.2018.02.020_bib30","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0140-6736(11)60993-8","article-title":"Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials","volume":"378","author":"Davies","year":"2011","journal-title":"Lancet"}],"container-title":["The American Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002961017313739?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002961017313739?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T18:13:45Z","timestamp":1757700825000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002961017313739"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S0002961017313739"],"URL":"https:\/\/doi.org\/10.1016\/j.amjsurg.2018.02.020","relation":{},"ISSN":["0002-9610"],"issn-type":[{"type":"print","value":"0002-9610"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differences between palpable and nonpalpable tumors in early-stage, hormone receptor-positive breast cancer","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjsurg.2018.02.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}